# Safety and Efficacy of TAF to Prevent MTCT of HBV in Middle/Late Pregnancies With High HBV DNA Load

> **NCT05466071** · — · UNKNOWN · sponsor: **Xingfei Pan** · enrollment: 200 (estimated)

## Conditions studied

- Chronic Hepatitis b
- Pregnancy Related

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05466071
- **Lead sponsor:** Xingfei Pan
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-01
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05466071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05466071, "Safety and Efficacy of TAF to Prevent MTCT of HBV in Middle/Late Pregnancies With High HBV DNA Load". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05466071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*